ScienceDex / Researcher record
O'Neill, John David
- Xylyx Bio, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2018 | $224,566 | 1 | #32,157 |
| 2019 | $54,875 | 1 | #42,179 |
| 2021 | $297,924 | 1 | #32,996 |
| 2022 | $950,532 | 1 | #10,482 |
| 2023 | $1,140,722 | 3 | #8,599 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20181 record
- FY20191 record
- FY20211 record
- FY20221 record
- FY2023 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing O'Neill, John David as a PI. Multi-PI records show the full award amount for context.
- 5R44HL158364-03R44Contact PILung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development$961.4Kaward amount
- 3R44HL158364-03S1R44Contact PILung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development$109.3Kaward amount
- 3R44HL158364-02S1R44Contact PILung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development$70Kaward amount
Award organization
Organizations that administered FY2023 awards listing O'Neill, John David as a PI.
FY2023 award administered by Xylyx Bio, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardXylyx Bio, Inc.
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #8599